Century Therapeutics, Inc. (IPSC)
1.275
-0.04
(-3.41%)
USD |
NASDAQ |
Oct 07, 16:00
1.34
+0.06
(+5.10%)
After-Hours: 20:00
Century Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2025 | 97.05% |
| December 31, 2024 | 20.49% |
| September 30, 2024 | -316.8% |
| June 30, 2024 | -349.0% |
| March 31, 2024 | -277.3% |
| December 31, 2023 | -1.23K% |
| September 30, 2023 | -1.11K% |
| Date | Value |
|---|---|
| June 30, 2023 | -2.33K% |
| March 31, 2023 | -26.16% |
| December 31, 2022 | -549.3% |
| September 30, 2022 | -24.73% |
| June 30, 2022 | -19.48% |
| March 31, 2022 | -9.64% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | -- |
| Exicure, Inc. | -- |
| Absci Corp. | -747.8% |
| Celularity, Inc. | 20.70% |
| Cardio Diagnostics Holdings, Inc. | -824.1% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -52.67% |
| Return on Assets | -40.17% |
| Return on Invested Capital | -43.26% |
| Return on Net Operating Assets | -107.6% |